| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |